ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2118

Risks of Fracture in Current and Previous Anticonvulsant Users, An Observational Study

Grace Hyeyeon Lee1, Hamzah Amin2 and marwan Bukhari1, 1University Hospitals of Morecambe bay NHS foundation trust, Lancaster, United Kingdom, 2Lancaster University, Lancaster, United Kingdom

Meeting: ACR Convergence 2025

Keywords: Bone density, Cohort Study, Drug toxicity, Epidemiology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2106–2123) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Anticonvulsants are commonly used to manage neurological and psychiatric disorders such as epilepsy, migraines and bipolar disorder. These medications are often prescribed long-term, and in some cases, lifelong. Prolonged anticonvulsant use has been associated with an increased risk of fractures in adults and lower bone mineral density in children, likely due to their effect on bone metabolism. This study aimed to investigate the association between fracture risk and anticonvulsant use in each group of patients who are currently taking anticonvulsants with those who have previously used them.

Methods: This retrospective study was conducted at a district general hospital in the northwest of England, from July 2004 to February 2024. There were 1,368 patients, with 332 patients who were previous anticonvulsant users and 1,036 patients who were current anticonvulsant users. In both groups, the predictors of fracture risk were examined, including age, gender, height, weight, body mass index (BMI), percentage total body fat, current smoker, current alcohol drinker, current steroid use, previous fractures and bone mineral density (BMD) values at the L1-L4 vertebrae, right and left femur neck, and right and left femur total. These factors were compared between the two groups of current and previous anticonvulsant users using independent t-tests for continuous factors and chi-square tests for categorical factors. A logistic regression model was used to assess the relationship between anticonvulsant use (current and previous users) and fracture risk (history of fracture), taking into account the predictors of fracture.

Results: The mean age was 65, and 87% were female in both groups. Initially the predictors of fracture were compared between current and previous anticonvulsant users; right and left femur neck and total BMD were found to be significantly lower in current anticonvulsant users (P< 0.05). In the first logistic regression analysis, the fracture risk was assessed in previous and current anticonvulsant users, taking into account the predictors of fracture. Current anticonvulsant users were associated with increased odds of fracture (OR = 1.48, 95% CI: 1.06–2.07, p = 0.020). Another independent factor, percentage total body fat, was also found to be significantly associated with fracture (p = 0.007). Second logistic regression analysis examined the interaction between anticonvulsant use and percentage body fat, which was not found to be significant (p = 0.288). This suggests that percentage body fat did not significantly change the association between anticonvulsant use and fracture risk.

Conclusion: In conclusion, the results show current anticonvulsant use is associated with an increased fracture risk, compared to previous users. In addition, the current anticonvulsant users were found to have lower femur neck and femur total BMD, which is likely to have an increased risk for major fractures. Percentage total body fat was an independent factor which was found to be a significant predictor of fracture risk.


Disclosures: G. Lee: None; H. Amin: None; m. Bukhari: None.

To cite this abstract in AMA style:

Lee G, Amin H, Bukhari m. Risks of Fracture in Current and Previous Anticonvulsant Users, An Observational Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/risks-of-fracture-in-current-and-previous-anticonvulsant-users-an-observational-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risks-of-fracture-in-current-and-previous-anticonvulsant-users-an-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology